Powder: -20°C for 3 years | In solvent: -80°C for 1 year
KP 10614 is a new prostacyclin analog that inhibits platelet-polymorphonuclear leukocyte interaction.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 10-14 weeks | $ 5,120.00 | |
50 mg | 10-14 weeks | $ 6,780.00 | |
100 mg | 10-14 weeks | $ 9,700.00 |
Description | KP 10614 is a new prostacyclin analog that inhibits platelet-polymorphonuclear leukocyte interaction. |
Molecular Weight | 372.5 |
Formula | C23H32O4 |
CAS No. | 130273-99-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
KP 10614 130273-99-3 FK070 KDI792 KP-10614 FK-070 KDI-792 HCl KDI-792 hydrochloride KDI 792 KP10614 inhibitor inhibit